M2 Archive: Preview
You haven't logged in. If you have archive credits in your account, please log in now to use them. If not, you can buy credits in our shopping area.
Cipla launches generic liraglutide injection in the US
Cipla USA Inc, a wholly owned subsidiary of Indian pharmaceutical company Cipla Limited (BSE: 500087; NSE: CIPLA), on Friday announced the launch of Liraglutide Injection 18 mg/3 ml, the generic equivalent of Saxenda, in single-patient-use prefilled pens.
This milestone follows an...
If you want to view the full text of this story, you must first purchase archive credits. Return to Archives
New Search